Gallardo, F., Mariamé, B., Gence, R., Tilkin-Mariamé, A., (FRANCE), N., (LBME), L. d. b. m. e., . . . (INSERM), I. N. d. l. S. e. d. l. R. M. (2018). Macrocyclic lactones inhibit nasopharyngeal carcinoma cells proliferation through PAK1 inhibition and reduce in vivo tumor growth. Drug Design, Development and Therapy, Volume 12, 2805.
Chicago Style (17th ed.) CitationGallardo, Franck, et al. "Macrocyclic Lactones Inhibit Nasopharyngeal Carcinoma Cells Proliferation Through PAK1 Inhibition and Reduce in Vivo Tumor Growth." Drug Design, Development and Therapy Volume 12 (2018): 2805.
MLA (9th ed.) CitationGallardo, Franck, et al. "Macrocyclic Lactones Inhibit Nasopharyngeal Carcinoma Cells Proliferation Through PAK1 Inhibition and Reduce in Vivo Tumor Growth." Drug Design, Development and Therapy, vol. Volume 12, 2018, p. 2805.